Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

BlackRock Health Sciences Opportunities Portfolio

+ Add to Watchlist

SHISX:US

54.21 USD 0.61 1.14%

As of 09:29:30 ET on 03/05/2015.

Snapshot for BlackRock Health Sciences Opportunities Portfolio (SHISX)

Year To Date: +9.36% 3-Month: +7.29% 3-Year: +31.63% 52-Week Range: 38.26 - 54.21
1-Month: +5.84% 1-Year: +27.03% 5-Year: +21.03% Beta vs SPX: 0.93

Mutual Fund Chart for SHISX

No chart data available.
  • SHISX:US 54.21
  • 1M
  • 1Y
Interactive SHISX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SHISX

BlackRock Health Sciences Opportunities Portfolio is an open-end fund incorporated in the USA. The Fund's objective is long-term growth of capital. The Fund normally invests at least 80% of total assets in securities of companies in health sciences and related industries.

Inception Date: 01-28-2005 Telephone: 1-800-441-7762
Managers: THOMAS P CALLAN / ERIN XIE
Web Site: www.blackrock.com

Fundamentals for SHISX

NAV (on 2015-03-05) 54.21
Assets (M) (on 2015-03-05) 5,473.38
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment 0.00

Dividends for SHISX

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2014-12-12) 0.01
Dividend Yield (ttm) 6.34

Fees & Expenses for SHISX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.70
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.20

Top Fund Holdings for SHISX

Filing Date: 01/30/2015
Name Position Value % of Total
Celgene Corp 1,550,138 184,714,444 3.661%
Biogen Idec Inc 441,312 171,740,978 3.404%
BlackRock Liquidity Funds Temp 158,071,383 158,071,383 3.133%
UnitedHealth Group Inc 1,346,282 143,042,463 2.835%
Medtronic PLC 1,963,223 140,174,136 2.778%
Alexion Pharmaceuticals Inc 753,017 137,982,835 2.735%
Amgen Inc 905,410 137,857,727 2.732%
AbbVie Inc 2,197,600 132,625,160 2.628%
McKesson Corp 591,300 125,739,945 2.492%
Actavis plc 454,046 121,021,421 2.398%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil